Aethlon Medical (AEMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2020 | 03-2019 | 03-2018 | 03-2017 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,380 | -6,220 | -5,700 | -7,307 | -4,959 |
| Depreciation Amortization | 57 | 152 | 281 | 253 | 556 |
| Accounts receivable | -207 | 75 | -75 | 200 | -6 |
| Other Working Capital | -115 | 436 | -294 | 458 | -129 |
| Other Operating Activity | 1,447 | 1,264 | 1,876 | 2,891 | 209 |
| Operating Cash Flow | $-5,198 | $-4,293 | $-3,911 | $-3,506 | $-4,329 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -152 | N/A | -25 | -16 | -9 |
| Investing Cash Flow | $-152 | $N/A | $-25 | $-16 | $-9 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 578 | N/A |
| Common Stock Issued | 12,160 | 1,341 | 9,629 | 2,759 | 5,607 |
| Other Financing Activity | -1,034 | -194 | -279 | -379 | 0 |
| Financing Cash Flow | $11,126 | $1,147 | $9,350 | $2,958 | $5,607 |
| Beginning Cash Position | 3,828 | 6,974 | 1,560 | 2,124 | 856 |
| End Cash Position | 9,605 | 3,828 | 6,974 | 1,560 | 2,124 |
| Net Cash Flow | $5,777 | $-3,146 | $5,414 | $-564 | $1,268 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,198 | -4,293 | -3,911 | -3,506 | -4,329 |
| Capital Expenditure | -152 | N/A | -25 | -16 | -9 |
| Free Cash Flow | -5,349 | -4,293 | -3,936 | -3,522 | -4,339 |